{"url_path":"/sec/cabr/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/2020737/0001493152-26-022506-index.html","accession_number":"0001493152-26-022506","cik":"0002020737","ticker":"CABR","issuer_name":"Caring Brands, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2020737/0001493152-26-022506-index.html","primary_entity_key":"0002020737","primary_entity_name":"Caring Brands, Inc."},"word_count":339,"has_tables":true,"body_markdown":"**Item\n6. Exhibits.**\n\n** **\n\n**Exhibit\nNumber**\n** **\n**Exhibit\nDescription**\n\n \n \n \n\n3.1\n \n[Amendment\nto the Bylaws of the Company (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on March\n31, 2026).](https://www.sec.gov/Archives/edgar/data/2020737/000149315226013808/ex3-1.htm)\n\n3.2\n \n[Certificate\nof Designation of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K\nfiled with the SEC on March 24, 2026).](https://www.sec.gov/Archives/edgar/data/2020737/000149315226012418/ex3-1.htm)\n\n10.1\n \n[License\nAgreement, dated December 31, 2025, by and between the Company and Itonis Pharmaceuticals (incorporated by reference to Exhibit 10.1\nto the Current Report on Form 8-K filed with the SEC on January 5, 2026)](https://www.sec.gov/Archives/edgar/data/2020737/000149315226000286/ex10-1.htm)\n\n10.2\n \n[Securities\nPurchase Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on March 24, 2026).](https://www.sec.gov/Archives/edgar/data/2020737/000149315226012418/ex10-1.htm)\n\n10.3\n \n[Registration\nRights Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on March 24, 2026).](https://www.sec.gov/Archives/edgar/data/2020737/000149315226012418/ex10-2.htm)\n\n10.4\n \n[Form\nof Share Redemption Agreement (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed with the SEC on\nMarch 24, 2026).](https://www.sec.gov/Archives/edgar/data/2020737/000149315226012418/ex10-3.htm)\n\n31.1*\n \n[Certification\nof the Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act.](ex31-1.htm)\n\n31.2*\n \n[Certification\nof the Interim Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act.](ex31-2.htm)\n\n32.1**\n \n[Certification\nof the Chief Executive Officer and Interim Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section\n906 of the Sarbanes-Oxley Act.](ex32-1.htm)\n\n104\n \nCover\nPage Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n \n\n*\n*Filed herewith.*\n\n***\nFurnished herewith*\n\n* *\n\n24\n\n[Table of Contents](#toc)\n\n* *\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its\nbehalf by the undersigned, thereunto duly authorized.\n\n \n\n \nCaring\nBrands, Inc.\n\n \n \n \n\nDate:\nMay 12, 2026\nBy:\n*/s/\nGlynn Wilson*\n\n \n \nDr.\nGlynn Wilson\n\n \n \nChief\nExecutive Officer\n\n \n \n*(Principal\nExecutive Officer)*\n\n \n \n \n\nDate:\nMay 12, 2026\nBy:\n*/s/\nBrian S John*\n\n \n \nBrian\nS John\n\n \n \nInterim\nChief Financial Officer and Chairman\n\n \n \n*(Principal\nFinancial and Accounting Officer)*\n\n \n\n25"}